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The adaptation of the cellular network to functional changes, timing and patterning of gene
expression is regulated by binding of transcription factors to gene regulatory elements, which
in turn depends on co-occurring histone modiﬁcations. These two layers inﬂuence each other,
enabling a further level of regulatory ﬁne-tuning. We analyzed the interdependencies between
histone 3 acetylation, histone 3 lysine 4 dimethylation, the transcription factor Srf and the histone
acetyltransferase p300 in an in vivo model using chromatin immunoprecipitation in a time-series
during cardiac maturation in mouse. We found a strong correlation between the presence of the
two histone modiﬁcations and binding of Srf and p300. Using linear modeling techniques we
could show that each factor contributes individually as well as conjointly to histone 3 acetylation
and gene expression, probably aided by accompanying histone 3 lysine 4 dimethylation. We
further demonstrate that changes in gene expression during cardiac maturation are attended by
changes of the analyzed regulators while revealing a high variability of combinatorial regulation.
Finally, we propose a model of Srf-driven gene expression in cardiomyocytes.
Introduction
Transcription factors can regulate the expression of genes in a
tissue-speciﬁc and quantitative manner and are thus major
regulators of embryonic developmental processes. The ability
of transcription factors to bind to DNA is highly dependent on
the accessibility of their binding sites. The majority of genomic
DNA in eukaryotes is packaged into chromatin by association
with histone proteins. Covalent modiﬁcations of histone tails
and ATP-dependent chromatin remodeling facilitate access for
DNA-binding transcription factors.1 Thus, to understand net-
works directing gene expression the interplay between transcrip-
tion factors, co-regulatory elements and epigenetic factors has
to be considered.
Serum Response Factor (Srf) is an ubiquitously expressed
MADS (MCM1, Agamous, Deﬁciens, SRF) box transcription
factor2 and binds to a DNA consensus sequence known as the
CArG box [CC(A/T)6GG]. Despite the ubiquitous expression
of SRF, the CArG box is predominantly found in promoters
of muscle- and growth-factor-associated genes.3,4 Functional
analyses showed that embryonic stem cells lacking Srf display
defects in spreading, adhesion and migration. These defects
correlate with defective formation of cytoskeletal structures.5
In Srf-null neonatal cardiomyocytes, severe defects in the con-
tractile apparatus are observed.6 Srf-deﬁcient mice embryos
(Srf/) show a gastrulation defect, fail to develop the meso-
derm and subsequently die between E8.5 and E12.5.7 Cre mice
with knockout of Srf in 80% of the cardiomyocytes display
severe heart defects and die at E11.58 and Cre mice lacking
skeletal muscle Srf expression die during the perinatal period
from severe skeletal muscle hypoplasia.9
Studies analysing co-occurring histone modiﬁcations showed
that histone H3 and H4 acetylation (H3ac andH4ac) are enriched
at CArG boxes in cultured smooth muscle cells (SMCs).3,10–12
Additionally, SMC genes show higher levels of H3 Lys4 dimethyl-
ation (H3K4me2) relative to non-SMC lineages.3 A model of
step-wise molecular events directing the activation of SMC gene
transcription has been depicted by McDonalds and Owens13
(Fig. 1A). It comprises the combinatorial enrichment of both
H3K4me2 and H4ac at regulatory CArG boxes of SMC genes.
H4ac is thought to lead to an open chromatin state facilitating
genomic access while H3K4me2 provides a docking site to the
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Srf/Myocardin complex.13 Myocardin, one of the most potent
co-activators of Srf, belongs to the SAP domain family of
nuclear proteins and is exclusively expressed in SMCs and
cardiomyocytes.14 Binding of the Srf/Myocardin complex to
the CArG box promotes the recruitment of other transcription
factors via the powerful C-term transcriptional activation
domain of Myocardin. Thus, the recruitment of the acetyl-
transferase p300 establishes additional histone acetylation
marks which in turn activate transcription.13 p300 is a known
histone acetyltransferase and transcriptional co-activator,
which was found to reside in enhancer and promoter regions.15,16
The model proposed has been established based on studies
in SMCs, however, a systematic validation in an in vivo model
comprising the dynamics of the interregulatory dependencies
is pending. Further, the relevance of factor interaction for
gene transcription in cardiomyocytes is unknown. Recently,
we showed that the transcriptional activity of Srf in the mouse
cardiomyocyte cell line HL-1 is highly depending on the
co-occurrence of H3ac. In contrast to SMCs H4ac marks do
not enhance Srf-driven gene expression in cardiomyocytes.17
To gain further insights, we used a time-series approach of
mouse hearts and monitored the combinatorial regulation of
gene expression driven by Srf, H3ac, H3K4me2, and p300. The
dynamic changes of transcription factor binding and depletion
or enrichment of histone modiﬁcations were studied during
the cardiac maturation process occurring at the prenatal and
postnatal developmental phase (E18.5, P0.5 and P4.5). Based
on our previous genome-wide study17 we selected 190 cardiac
enhancer and promoter regions for this focused approach and
used chromatin immunoprecipitation (ChIP) followed by high-
throughput qPCR to quantify respective dynamics. In addition,
we measured the corresponding changes of genes expression
showing the functional consequences of the observed altera-
tions of factor binding and histone modiﬁcations. Based on our
ﬁndings we propose a model of Srf-driven gene expression in
cardiomyocytes (Fig. 1B).
Results and discussion
Our previous analysis performed in a cardiomyocyte cell line
(HL-1) showed that the activating potential of Srf is signiﬁ-
cantly depending on accompanying H3ac.17 In contrast to the
Srf-driven gene expression model proposed for SMC, we do
not observe a dependency for H4ac or H3K4me2 (Fig. 2). To
further elaborate on the dynamic relationship between Srf and
histone modiﬁcations, we switched towards an in vivo time-
series model of cardiac maturation in mouse and investigated
Fig. 1 (A) Model for smooth muscle cell (SMC) gene activation adapted from McDonald and Owens.13 H4ac and H3K4me2 facilitate the
binding of the Srf/Myocardin complex to regulatory CArG boxes. The complex then recruits p300, leading to further histone acetylation and active
gene expression. (B) Model for Srf-driven gene expression in cardiomyocytes. In contrast to SMC, H3ac takes over the role of H4ac in facilitating
gene expression. Furthermore, histone acetylation by p300 is accompanied by additional so far unexplored histone acetyltransferases (HAT).
Fig. 2 The inﬂuence of histone modiﬁcations at Srf binding sites on
expression levels. Boxplots for the expression of transcripts with Srf
binding site and speciﬁc histone modiﬁcations compared to genes with
Srf binding site but no histone modiﬁcation. A single transcript can
belong to multiple groups if it has multiple histone modiﬁcations.
Estimates for the inﬂuence of individual histone modiﬁcations and their
associated p-values are derived by an ANOVA model. Figure taken
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the relationship between binding of Srf, the acetyltransferase
p300 and H3ac as well as H3K4me2. We included H3K4me2
in our further studies even though we did not observe an
enhancement of Srf-driven gene expression in our cell line
analyses. H3K4me2 had been shown to function as a stabiliz-
ing element for Srf binding and therefore might act in concert
with H3ac. This could potentially be underlined by our pre-
vious observation that co-localization of H3ac and H3K4me2
is associated with higher gene expression than isolated
H3K4me2 marks.18
We used mouse hearts of three developmental stages (Fig. 3A),
one prenatal stage (E18.5) and two postnatal stages (P0.5, P4.5).
From the fetal to the postnatal stage, the heart adapts to the
body circulation and cardiomyocytes mature. During this
process the heart increases in size, the cells elongate, myoﬁbrils
align and cell–cell contacts become bipolar.19
As an initial step, we determined total protein levels of Srf,
p300, H3ac, H3K4me2, total H3 and GAPDH (normalization
control) at all stages using Western Blot followed by densi-
tometric measurements of the resulting bands (Fig. 3B and C).
Due to alternative splicing events of Srf, four diﬀerent iso-
forms are expressed in the heart,20,21 showing only slight
changes during the time-series. The level of p300 is strongly
reduced at P4.5 (85% compared to E18.5). Both, the levels of
H3ac and H3K4me2, show a high reduction directly after birth
(75–91% compared to E18.5) whereas the total amount of H3
remains nearly constant.
We selected enhancer and promoter regions with potential
Srf-driven regulatory inﬂuence on gene expression based on
our previous genome-wide ChIP-chip/seq data of histone modi-
ﬁcations and Srf binding (see Fischer et al.18 and Schlesinger
et al.17). A priori 422 genomic regions that shared enrichment
for at least two of H3ac, H3K4me2 and Srf binding were
selected located in a 10 kb window of genes involved in cardiac
development. We used a multistep ﬁltering approach to focus
on genes with either heart or muscle annotation as a GO term,
an entry of cardiac disease in OMIM or relevance in a manually
curated literature search. Genomic regions of a maximum of
500 bp in length were deﬁned (Fig. S1, ESIw) and Taq Man
assays for the following ChIP analysis were established for every
window. Windows without unique primer pairs were discarded
from the analysis. This resulted in a total of 190 genomic regions
in the proximity of heart and muscle developmental genes, which
were consequently analyzed.
ChIP followed by real-time qPCR was performed for each
factor plus input DNA for each region with samples of mouse
hearts of the time points E18.5, P0.5 and P4.5 in triplicates.
This resulted in a total of 7578 measurements, which fulﬁlled
our quality standards. Data normalization was performed
computing DCP values using the measured input DNA. As a
proof of principle, the resulting ChIP enrichments from stage
P0.5 were compared to our previous ChIP-chip/seq results in
HL-1 cells (Fig. S2, ESIw), which conﬁrmed the reliability of
the system. As we were interested in the dynamic changes of
factor binding and histone modiﬁcation over the time course, we
checked for a potential overall bias, which might be introduced
by the observed changes of the protein content during the time
course. Consequently, we compared the average ChIP enrich-
ment over all regions for each factor in each stage and found
diﬀerences between the three stages (Fig. 3D and Fig. S3A,
ESIw) recapitulating the ﬁndings from the overall protein
analysis (Fig. 3B and C). We eliminated this bias, as it would
result in a general trend between individual stages and
superﬁcially high correlations between the individual factors.
Therefore, we introduced a ﬁxed linear shift for each single
region and each single factor resulting in the same average
enrichment in each stage for each factor (Fig. S3B, ESIw).
Finally, we calculated for each factor fold changes of ChIP
enrichments between consecutive stages and grouped all
changes into the categories signiﬁcantly up, signiﬁcantly down
or unchanged according to a t-test using a signiﬁcance level
of 95%.
As a ﬁrst analysis, scatter plots were used to visualize the
level of correlation between the fold changes of individual
factors (Fig. 4). We found high to modest correlation for
all the measured factors, with Pearson correlation coeﬃcients
ranging from 0.753 to 0.364, which implicates that all factors
are related to each other. Statistical signiﬁcance of found corre-
lation coeﬃcients was evaluated using random experiments.
As a null model, triplicate measurements for one factor and
time point were randomly assigned to all regions without
replacement and fold changes were again computed between
successive timepoints. This process was repeated 20 000 times
and an empirical p-value was derived by counting the number
of tries where the random correlation coeﬃcient exceeded the
true coeﬃcient. Applying a signiﬁcance level of 99.9% we
found signiﬁcant correlation for all of the analyzed pairings
(Fig. S4, ESIw).
Fig. 3 (A) Three stages of mouse hearts during cardiomyocyte matu-
ration around birth. Figure taken from Schlesinger et al.,17 modiﬁed.
(B) Western Blot analysis of protein expression in mouse hearts for Srf,
p300, H3ac, H3K4me2 and H3. GAPDH served as loading control. Srf
is expressed in four diﬀerent isoforms. The H3 level is divided in
phosphorylated H3 (upper band) and non-phosphorylated H3 (lower
band). (C) Barplot of relative protein expressions of Srf, p300 and H3
and relative levels of histone modiﬁcations H3ac and H3K4me2. Total
protein amounts were gathered using repeated densitometry measure-
ments. All intensities are normalized to GAPDH and shown relative to
E18.5. (D) Barplot of relative average ChIP level over all regions for
every factor in every stage. Measurements after DCP normalization
showing a distinct trend between the individual stages. Consequently,
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The highest correlation coeﬃcient of 0.753 was found between
the changes in H3ac and H3K4me2 which is in accordance to
the high correlation of absolute H3ac and H3K4me2 levels
found by us17 and others.22 A recent study performed by Wang
et al.23 suggested that H3K4methylation might directly facilitate
histone acetylation events. The second highest correlation coeﬃ-
cient (0.593) was found between changes in H3ac enrichment
and p300 followed by p300 and H3K4me2 (0.547). While the
correlation between changes in p300 and acetylation level was
highly expected given the function of p300, the correlation
between p300 and methylation level is of high interest. A possible
explanation for this correlation supposed by Pray-Grant et al.24
and Wysocka et al.25 is an initial opening of chromatin through
recruitment of ATP-dependent chromatin remodeling complexes
induced by histone methylation which in turn allows p300 to
bind. Another possibility might be the direct recognition of
methylated sites by histone acetylation complexes (including
p300) as suggested by Martin et al.26 In addition, signiﬁcant
correlation was found between Srf and H3ac (0.489) as well as
Srf and H3K4me2 (0.481) supporting the model by McDonald
and Owens13 which suggest stabilization of Srf binding to the
CArG box DNA motif via Myocardin or some Myocardin
related factors that directly bind methylated histones. Further,
this ﬁnding is in line with our previous observation in HL-1
cells such that siRNA mediated knockdown of Srf leads to a
signiﬁcant reduction of H3 acetylation at related genomic
sites.17 Consistent with the model in SMCs, signiﬁcant correla-
tion was found between changes in Srf and p300. However,
given that the observed correlation (0.364) between these two
factors is much weaker than between any of the other measured
factors and especially between Srf and H3ac might suggest
additional mechanisms of Srf-triggered acetylation, which are
independent from p300 binding.
While our ﬁrst analysis of correlation between changes in
the individual factors was based on the combination of fold
changes between all three stages, we also considered each fold
change individually. In general, fold changes as well as corre-
lation coeﬃcients were higher for changes between E18.5 and
P0.5 than between P0.5 and P4.5 while, except for Srf and
p300, still remaining signiﬁcant. A possible explanation is that
the physiological and cellular change reﬂected in the molecular
setting is greater from the pre- towards the postnatal phase
than later on. This might cause a higher inﬂuence of experi-
mental noise on the correlation.
To analyze the interdependency in regulation of the measured
factors, we used ANOVA linear models to predict changes in
H3ac modiﬁcation levels from changes in binding levels of p300
and Srf. We excluded the data for H3K4me changes as these
were shown to be highly correlated with the dependent variable
H3ac and could therefore obscure the models. After estimating
coeﬃcients for each of the predictive groups using a least-square
approach, it was tested whether any of the coeﬃcients was
signiﬁcantly diﬀerent from zero implying a signiﬁcant inﬂuence
on changes in H3ac level. As before, randomized experiments
were used to derive empirical p-values for the individual models,
now using the percentage of variance explained or R2 as a measure-
ment for the goodness of ﬁt for each model.27 The empirical
p-value is therefore determined by the number of random
models which yielded a higher R2 when compared to the
original model. Two single-factor ANOVAs were calculated
using only categorized changes in either p300 or Srf to predict
changes in H3ac (Fig. 5A and B). Both models indicated a
signiﬁcant dependency of H3ac on the individual factor with
an empirical p-value o 5  105. The estimated coeﬃcients
for up and down regulated regions were signiﬁcantly higher
and lower than zero. The distribution of the residuals and the
Fig. 4 Scatter plots of fold changes between the measured factors (combined time points). Red dots represent measurements with signiﬁcant
change for at least one of the factors. Lines represent the best linear ﬁt for all measurements. Pearson correlation coeﬃcients for all measurements
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normal Q-Q plots indicated validity of the linear model assump-
tions for both single-factor ANOVAs (Fig. S5, ESIw).
After proving the dependency of H3ac changes on each Srf
and p300 individually, we were interested in the interaction
between the two and if the observed changes were mainly
dependent on the interplay between the two factors or on both
factors independently. Therefore, a two-factor ANOVA was
performed using categorized changes in both Srf as well as
p300 as predictors for changes in H3ac (Fig. 5C). Again,
the model indicated signiﬁcant dependency with an empirical
p-value o 5  105. Like in the single-factor ANOVA, the
estimated coeﬃcients for the inﬂuence of up and down regulation
of Srf and p300, which can be found in Table 1, were signiﬁcantly
diﬀerent from zero, with the exception of up-regulated Srf
regions. As a result, changes in both p300 and Srf had a
signiﬁcant inﬂuence on H3ac. Reduction of Srf binding on top
of reduced p300 levels leads to further diminishment of H3ac,
which substantiates the assumption that Srf triggers H3ac
additionally by a p300 independent mechanism. This eﬀect
appears not to be as pronounced for regions of elevated Srf and
p300 levels. One possible explanation is that both p300
and Srf serve as necessary components for histone acetylation
and thus reducing the level of each factor reduces H3ac.
Increasing their levels may not increase H3ac due to shortage of
other necessary components. One suggestive co-player is
Myocardin. Another possible explanation is the much lower
number of regions with elevated Srf and p300 levels, which is
likely correlated to the high number of genes that are active
during development but are shut down afterwards. This lower
number might have resulted in reduced statistical power for
regions of elevated Srf and p300 levels. Like for the single-
factor ANOVAs, the distribution of the residuals and the
normal Q-Q plots indicated validity of the linear model
assumptions (Fig. S6, ESIw).
To gain insights of H3ac levels in regions with steady state
levels of Srf and p300, we used density plots of mean levels for
H3ac, p300 and Srf over all regions. We were interested if these
stable Srf and p300 regions had a general preference in their
absolute H3ac levels, such that higher p300 levels are asso-
ciated with higher H3ac levels. Fig. 5D shows the density plot
of mean levels for H3ac over all regions. It indicates a bimodal
distribution with two peaks that correlate with regions of high
and low acetylation levels. The same two peaks were found in
a two-dimensional density plot for absolute H3ac and p300
levels (Fig. 5E). We did not observe a bimodal distribution for
Srf (data not shown). However, in both plots the two peaks are
not perfectly separated, indicating many regions with inter-
mediate H3ac and p300 levels.
In line with this qualitative assessment of H3ac in steady
state regions of Srf and p300, we were interested if the dynamics of
H3ac levels were also quantitatively dependent on the dynamics
of Srf and p300 levels. In other words, if stronger changes in any of
Fig. 5 (A–C) ANOVA models predicting changes in H3ac (combined time points). Boxplots illustrating the dependence of changes in H3ac from
grouped signiﬁcant changes in (A) Srf, (B) p300 and (C) Srf and p300. Signiﬁcance levels indicating diﬀerence from zero according to the single-
factor ANOVA models are given above each box, using the following coding: *p o 0.05, ***p o 0.001. Estimated coeﬃcients and respective
p-values for the two-factor ANOVA model can be found in Table 1. (D) Density of H3ac enrichment levels of region without a signiﬁcant change
in both Srf and p300 using a bandwidth of 0.253 and n = 227 observations. (E) Two-dimensional density for H3ac and p300 enrichment levels.
The height is indicated using the color key on the right.
Table 1 Estimates and p-values of two-factor ANOVA. The p-values are based on F statistic and reﬂect the signiﬁcance of the estimates diﬀerence
from zero. All estimates are in log space
— p300 up p300 down Srf up Srf down
Coeﬃcient 0.03483 0.12557 0.32705 0.06896 0.18069
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these two factors lead to stronger changes in H3ac and which of
the two factors is more inﬂuential. Therefore, a linear regression
model was computed predicting the strength of H3ac fold changes
from Srf and p300 fold changes directly. Like for the previous
models, an empirical p-value was derived from random experi-
ments. Again, the residuals and the Q-Q plots revealed validity of
the linear model assumptions (Fig. S7A and B, ESIw).
The linear regression model revealed that changes in H3ac
level were not only qualitatively but also quantitatively depen-
dent on changes in Srf as well as p300 level (po 5  105). In
line with the results from the qualitative model, both factors
showed a signiﬁcant inﬂuence and to a roughly equal extend
according to the high similarity in their estimated coeﬃcients
(Table 2). This ﬁnding further questions the proposed depen-
dency between the two factors in the analyzed time-series,
indicating p300-independent mechanisms of Srf-triggered
H3ac. Finally, we computed the Pearson correlation coeﬃcient
between predicted and observed changes reaching an overall
model accuracy of 0.67 (Fig. S7C, ESIw). While far from
perfect, this correlation demonstrates that changes in the two
factors Srf and p300 already drive an appreciable fraction of the
measured changes in histone 3 acetylation levels.
So far we used changes in H3ac level as the predicted read-
out of changes in Srf and p300 level. In a last step, we were
interested whether the observed changes also had a functional
consequence on gene expression. Therefore, gene expression
levels for 44 genes associated to one or multiple analyzed
regulatory regions were measured in the same three stages
using quantitative real-time PCR. Like for the ChIP measure-
ments, a normalization step was introduced to remove potential
trends in the mean expression over all measured genes between
the three individual stages and fold changes were calculated
to measure the eﬀective change between the individual stages.
To check whether changes in the individual factors lead to
changes in gene expression, genes were grouped according
to signiﬁcant up or down regulated regions for each factor
combining the two time points. Using a t-test between the
two groups, we observed signiﬁcant dependencies for changes
of gene expression to changes of H3ac and Srf levels (p =
0.017 and p = 0.03, respectively, Fig. 6A and B) and only an
insigniﬁcant trend for p300 levels (data not shown).
In addition, we analyzed the dependency of gene expression
changes on all measured factors and histone modiﬁcations.
While the genes in general showed the proposed dependency
on binding or modiﬁcation changes, several were regulated by
only subgroups of these (representative examples are shown in
Fig. 6C–H). This ﬁnding likely indicates a high variability of
combinatorial regulation between the investigated regulators.
Though, it has to be kept in mind that we measured only three
consecutive timepoints and might therefore have missed inter-
mediate regulatory events.
Summary and conclusion
We investigated the interdependency between Srf and H3ac in
conjunction with H3K4me2 and the acetyltransferase p300
in vivo using a time-series of maturating murine cardio-
myocytes around birth. With respect to the limited amount
of cardiac material, regulatory regions were selected that
showed binding of at least two of the three factors Srf, H3ac
and H3K4me3 in a preceding HL-1 study. These regions were
subsequently proﬁled for their enrichment with the analyzed
factors and histone modiﬁcations. Investigating changes
between the successive stages, binding of the individual factors
was in general found to be very dynamic with many signiﬁcant
changes between the individual stages. Most importantly,
these changes showed high levels of correlation pointing to
strong interdependencies. While a high correlation between
changes of the histone acetyltransferase p300 and acetylation
level was expected, the link between the other factors is not
straightforward. Interestingly, the highest correlation was found
between changes in H3ac and H3K4me2 levels. This supports
ﬁndings from Wang et al.23 in human CD4+T cells which
revealed that histones in promoters that showed initial H3K4
methylation were acetylated after treatment with Trichostatin A,
an histone deacetyltransferase inhibitor, while those promoters
that did not had initial H3K4 methylation remained largely
unacetylated. The coupling between histone tail methylation
and acetylation might either be achieved through chromatin
remodelers binding both modiﬁcations such as Dpf3b (Baf45c)28
or BPTF,29,30 the recruitment of ATP-dependent chromatin
remodeling complexes which open the chromatin to allow other
histone modiﬁcation enzymes to bind24,25 or by direct H3K4me2
recognition from histone acetylation complexes.26
Further, it has been suggested that H3K4 methylation
increases the eﬃciency of p300 function and consecutive
histone acetylation.31 In line with this we found signiﬁcant
correlation between changes in H3K4me2 and p300 levels and
ﬁnally coupling to H3ac, which might likely be established
through tissue speciﬁc transcription factors. Following a
model suggested by McDonald and Owens,13 gene activation
by Srf is performed in a step-wise procedure. In order to
bind its CArG-box motif, initial histone modiﬁcations like
H3K4me2 and H4ac must be present in smooth muscle cells.
H4ac thereby leads to an open chromatin state facilitating
genomic access while H3K4me2 provides a docking site to the
Srf/Myocardin complex. This complex has been suggested
to recruit further transcription factors and transcriptional
co-factors including p300 that fully activate the gene expres-
sion program. Here, we focused on cardiomyocytes matura-
tion using an in vivo time-series model and suggest that H3ac
instead of H4ac plays a crucial role for Srf-driven gene
expression. Both quantitative and qualitative modeling of
changes in H3ac showed a signiﬁcant dependency on Srf and
p300 levels either alone or in conjunction. A key question was
whether the implemented models would substantiate the step-
wise regulatory model in which H3ac levels are dependent on
Srf binding through recruitment of p300 or if the presence of
both factors independently inﬂuences H3ac levels. We found a
minor correlation between Srf and p300 levels, however, both
qualitative as well as quantitative linear modeling revealed a
Table 2 Estimates and p-values of a linear regression model. The
p-values are based on F statistic and reﬂect the signiﬁcance of the
estimates diﬀerence from zero. All estimates are in log space
Intercept Srf p300
Coeﬃcient 0.00622 0.31083 0.32681
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signiﬁcant inﬂuence of Srf as well as p300 on H3ac levels,
pointing to independent regulation. We therefore strongly
believe that Srf-associated H3ac is not only achieved via the
recruitment of p300 but is established by the interaction with
additional histone acetylation factors. Furthermore, we found
for cardiac relevant genes that gene expression levels and the
presence of H3ac and Srf binding are highly correlated which
does not apply for p300. Notably, on the single-gene level a
panel of regulatory dependencies can be observed with dynamic
subsets of regulators that co-operatively work to regulate correct
temporal transcription of target genes.
Materials and methods
Cardiac samples
Mouse hearts at the indicated stages of CD1 strain were
dissected in cold PBS from the rest of the body. For subsequent
RNA isolation heart samples were directly snap frozen in liquid
nitrogen and stored at 80 1C. For ChIP experiments heart
samples were minced and ﬁxed with 1% formaldehyde solution.
Chromatin immunoprecipitation followed by qPCR
Chromatin immunoprecipitation (ChIP) experiments were per-
formed using 30 mgmouse heart tissue each. Tissue samples were
minced and cross-linked for 15 min at room temperature with
ﬁxation buﬀer (1% formaldehyde, 10 mM NaCl, 100 mM
EDTA, 50 mM EGTA, 5 mM HEPES, pH 7.5). Cross-linking
was terminated by addition of glycine to a ﬁnal concentration
of 125 mM. Tissue samples were homogenized for disaggrega-
tion. Subsequently, cells were incubated for 15 min at 4 1C
with lysis buﬀer (50 mM HEPES, pH 7.5, 140 mM NaCl,
1 mM EDTA, 1% Triton, 0.1% Na–deoxycholate, 0.1% SDS,
1 mM PMSF, 1 Complete Protease Inhibitor Cocktail
(Roche)), collected by centrifugation and homogenized using
a Douncer. Nuclei were collected by centrifugation for 15 min
at 20 000g and 4 1C and resuspended in soniﬁcation buﬀer
(10 mM Tris–HCl, pH 8.0, 1 mM EDTA and 0.5 mM EGTA,
1 mM PMSF, 1 Complete Protease Inhibitor Cocktail). The
chromatin was fragmented by soniﬁcation to an average size
of 500 bp. For immunoprecipitation buﬀer conditions were
adjusted to the following concentrations: 140 mM NaCl, 1%
Triton, 0.1% SDS, 0.1% Na–deoxycholate. A fraction of
material was saved as ‘‘Input’’. Chromatin was pre-cleared
by rotation with Dynabeads Protein A/G (Invitrogen) for 1 h
at 4 1C. Antibodies were added as given in Table S1 (ESIw) and
incubated on a rotating wheel over night at 4 1C. Protein A/G
beads were added and rotation continued for 1 h. The beads
were washed twice with RIPA buﬀer A (10 mM Tris–HCl,
pH 8.0, 140 mM NaCl, 0.025% NaN3, 1% Triton, 0.1% SDS,
1% Na–deoxycholate), once with RIPA buﬀer B (10 mM
Tris–HCl, pH 8.0, 500 mM NaCl, 0.025% NaN3, 1% Triton,
0.1% SDS, 1% Na–deoxycholate), once with LiCl detergent
Fig. 6 (A + B) Gene expression changes grouped by signiﬁcant up or down regulation of H3ac and Srf. Boxplots illustrating the dependence of
changes in expression level from signiﬁcant changes in (A) H3ac and (B) Srf. (C–H) Representative examples of variable gene regulation. (C) All
factors and histone modiﬁcations correlate with gene expression. (D–G) All factors and histone modiﬁcations correlate with gene expression with
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solution (10 mM Tris–HCl, pH 8.0, 0.5% Na–deoxycholate,
1 mM EDTA, 250 mM LiCl, 0.5% Nonidet P-40) and once
with TBS (20 mM Tris–HCl, pH 7.6, 150 mM NaCl). Immuno-
complexes were disrupted by eluting 10 min at 65 1C with
1% SDS/TE buﬀer (10 mM Tris–HCl, pH 7.6, 1 mM EDTA,
1% SDS) and eluting a second time for 15 min with 0.67%
SDS/TE buﬀer (10 mM Tris–HCl, pH 7.6, 1 mM EDTA,
0.67% SDS). Eluates were combined and reverse cross-linked
by heating at 65 1C over night. Subsequently, DNA was treated
with RNase A and Proteinase K and puriﬁed by phenol–
chloroform extraction.
ChIP samples of Srf, p300, H3ac and H3K4me2 for 190
regions (Table S2, ESIw) were analyzed with TaqMan qPCR in
context of a beta-side testing of the LightCyclers 1536 System
fromRoche Applied Science. TaqMan qPCR assays were designed
using the Universal ProbeLibrary (UPL) and the ProbeFinder soft-
ware which is freely accessible at www.roche-appliedscience.com.
For the 1536-well plate format the Innovadynet Nanodropt
Express pipetting robot (IDEX Health & Science LLC, Rohnert
Park, CA, USA) and the Velocity11 sealing machine (Agilent,
Santa Clara, CA, USA) were used. ChIP analysis was carried out
in triplicates using the following program: enzyme activation: 95 1C
for 1min; ampliﬁcation (45 cycles): 95 1C for 1 s (ramp: 4.8 1C s1),
60 1C for 30 s (ramp: 2.5 1C s1); cooling: 40 1C for 30 s (ramp:
2.5 1C s1). The detection format was set to ‘Mono Color
Hydrolysis/UPL Probes’ and the pipetting control to ‘Master
Control’. The qPCR reaction contained 0.8 ml ChIP sample
and 1.2 ml mastermix containing 1 RealTime ready DNA
Probes Master, 300 nM primer and 400 nM probe.
Preparation of protein extracts and Western Blot analysis
Protein extraction and Western Blot were performed accord-
ing to standard protocols. All antibodies with their respective
dilution are given in Table S1 (ESIw). Signals on the blots were
subjected to densitometry measurements using NIH’s ImageJ
software.
mRNA expression analysis
Total RNA of heart tissues was isolated using TRIzol reagent
(Invitrogen) followed by DNase digest (Promega) and ethanol
precipitation according to standard protocols. Reverse tran-
scription reactions were carried out via AMV-RT (Promega)
with random hexamers (Amersham Pharmacia Biotech). To
verify transcript expression levels of mouse hearts, quantitative
real-time PCR measurements were performed using Absolute
qPCR SYBR Green ROX Mix (Thermo Scientiﬁc) and the ABI
PRISM 7900HT Sequence Detection System according to manu-
facturer’s protocol. Gene expression was calculated using the
DCT method with normalization to the housekeeping gene Hprt.
Genes and corresponding primer sequences can be found in
Table S3 (ESIw).
Bioinformatic analysis
All computations, linear models, statistical tests and plots were
carried out using R.32 The two-dimensional density plot was
computed using the kde2d function from R’s MASS package.33
Gene annotations were based on Ensembl, version 55.
To assess the inﬂuence of the individual factors on gene
expression for genes with multiple assigned ChIP regions, the
changes for these regions were combined using the following
algorithm for each factor and time point comparison indivi-
dually: At ﬁrst, changes were categorized into up, down and
unchanged as described in the manuscript. In a second step,
genes that were associated to both up and down regulated
regions were discarded from the analysis. Finally, genes which
were associated to at least one region with a signiﬁcant change
were categorized accordingly and genes associated to only
unchanged regions were discarded.
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